|
UBE4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.362900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.776100E-02 |
| Normal-vs-Stage2 |
4.209400E-01 |
| Normal-vs-Stage3 |
1.445890E-02 |
| Normal-vs-Stage4 |
3.81580000000659E-05 |
| Stage1-vs-Stage2 |
7.466400E-01 |
| Stage1-vs-Stage3 |
2.101400E-01 |
| Stage1-vs-Stage4 |
5.329500E-02 |
| Stage2-vs-Stage3 |
2.630000E-01 |
| Stage2-vs-Stage4 |
6.025800E-02 |
| Stage3-vs-Stage4 |
3.070000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.935600E-03 |
| Normal-vs-AfricanAmerican |
1.209970E-01 |
| Normal-vs-Asian |
1.851970E-02 |
| Caucasian-vs-AfricanAmerican |
5.824600E-01 |
| Caucasian-vs-Asian |
5.089200E-01 |
| AfricanAmerican-vs-Asian |
3.967400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.437400E-04 |
| Normal-vs-Female |
8.157600E-01 |
| Male-vs-Female |
2.014000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.549700E-02 |
| Normal-vs-Extreme_Weight |
2.603100E-03 |
| Normal-vs-Obese |
1.346220E-01 |
| Normal-vs-Extreme_Obese |
3.273800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.558800E-01 |
| Normal_Weight-vs-Obese |
5.363400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.152200E-01 |
| Extreme_Weight-vs-Obese |
2.230600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.827600E-01 |
| Obese-vs-Extreme_Obese |
5.386200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.263600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.614000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.023960E-04 |
| Normal-vs-Age(81-100Yrs) |
2.571600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.285400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.518240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.717800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.397250E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.353600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.691400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.648300E-02 |
| Normal-VS-Type2 PRCC |
1.988720E-04 |
| Normal-VS-KIRP CIMP |
6.355600E-01 |
| Normal-VS-Unclassified PRCC |
5.072600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.760800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.714600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.561600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.643800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.130210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.454000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.985000E-04 |
| Normal-vs-N1 |
5.345000E-03 |
| Normal-vs-N2 |
6.44880000000292E-05 |
| N0-vs-N1 |
6.954600E-01 |
| N0-vs-N2 |
6.48319999999591E-05 |
| N1-vs-N2 |
8.400900E-03 |
|
|
